Shasqi, Inc
- Biotech or pharma, therapeutic R&D
Shasqi is a preclinical stage biotech company developing oncology drugs using pretargeting in vivo click chemistry technology (2022 Nobel Prize winner) to activate cancer drugs directly at tumors with applications to ADCs and radiotherapeutics (RLTs, TRTs).